Evidence map›Paper›PMID 36711570›Full record

ArticlebioRxiv : the preprint server for biology2023

Damage-induced pyroptosis drives endog thymic regeneration via induction of Foxn1 by purinergic receptor activation.

Sinéad Kinsella, Cindy A Evandy, Kirsten Cooper, Antonella Cardinale, Lorenzo Iovino, Paul deRoos, Kayla S Hopwo, Colton W Smith, David Granadier, Lucas B Sullivan and 2 more

Open access · greenAbstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 7 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 3 countries.

Sinéad KinsellaProgram in Immunology, Division of Translational Science and Therapeutics, Fred Hutchinson Cancer Center, Seattle WA, 98109, US.
Cindy A EvandyProgram in Immunology, Division of Translational Science and Therapeutics, Fred Hutchinson Cancer Center, Seattle WA, 98109, US.
Kirsten CooperProgram in Immunology, Division of Translational Science and Therapeutics, Fred Hutchinson Cancer Center, Seattle WA, 98109, US.
Antonella CardinaleDepartment of Pediatric Hematology and Oncology, Bambino Gesù Children's Hospital, IRCCS, Rome, 00146, Italy.
Lorenzo IovinoProgram in Immunology, Division of Translational Science and Therapeutics, Fred Hutchinson Cancer Center, Seattle WA, 98109, US.
Paul deRoosProgram in Immunology, Division of Translational Science and Therapeutics, Fred Hutchinson Cancer Center, Seattle WA, 98109, US.
Kayla S HopwoProgram in Immunology, Division of Translational Science and Therapeutics, Fred Hutchinson Cancer Center, Seattle WA, 98109, US.
Colton W SmithProgram in Immunology, Division of Translational Science and Therapeutics, Fred Hutchinson Cancer Center, Seattle WA, 98109, US.
David GranadierProgram in Immunology, Division of Translational Science and Therapeutics, Fred Hutchinson Cancer Center, Seattle WA, 98109, US.
Lucas B SullivanHuman Biology Division, Fred Hutchinson Cancer Center, Seattle WA, 98109, US.
Enrico VelardiDepartment of Pediatric Hematology and Oncology, Bambino Gesù Children's Hospital, IRCCS, Rome, 00146, Italy.
Jarrod A DudakovProgram in Immunology, Division of Translational Science and Therapeutics, Fred Hutchinson Cancer Center, Seattle WA, 98109, US.
Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa · ZABambino Gesù Children's Hospital · ITFred Hutch Cancer Center · US

Funding

Translational Bioimaging Core Shared ResourceP30CA015704 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Eric Collisson · 1985 to 2026
$296.4M
Thymic and Peripheral Aspects of T Cell Aging and RejuvenationP01AG052359 · NIA · UNIVERSITY OF ARIZONA · PI Bonnie LaFleur · 2017 to 2026
$23.5M
Stem Cell and Transplantation BiologyU54DK106829 · NIDDK · FRED HUTCHINSON CANCER RESEARCH CENTER · PI DEREK L STIREWALT · 2015 to 2026
$9.1M
Modulation of signaling from damage-associated molecular patterns to improve radiation-induced thymic dysfunctionU01AI170035 · NIAID · FRED HUTCHINSON CANCER CENTER · PI Jarrod Dudakov · 2022 to 2026
$3.0M
Harnessing endogenous mechanisms of thymic regeneration toboost immune function in recipients of hematopoietic cell transplantR01HL145276 · NHLBI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI DUDAKOV, JARROD · 2019 to 2023
$2.8M
Regulation of thymic regeneration by GPR39R01HL165673 · NHLBI · FRED HUTCHINSON CANCER CENTER · PI DUDAKOV, JARROD · 2022 to 2023
$1.2M
Investigating the role of interleukin-22 in thymus functionR00CA176376 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI DUDAKOV, JARROD · 2016 to 2018
$741k
NCI NIH HHS P30 CA015704NCI NIH HHS R00 CA176376NHLBI NIH HHS R01 HL145276NHLBI NIH HHS R01 HL165673NIAID NIH HHS U01 AI170035NIA NIH HHS P01 AG052359NIDDK NIH HHS U54 DK106829
6 · The paper itself

Abstract

Endogenous thymic regeneration is a crucial process that allows for the renewal of immune competence following stress, infection or cytoreductive conditioning. Fully understanding the molecular mechanisms driving regeneration will uncover therapeutic targets to enhance regeneration. We previously demonstrated that high levels of homeostatic apoptosis suppress regeneration and that a reduction in the presence of damage-induced apoptotic thymocytes facilitates regeneration. Here we identified that cell-specific metabolic remodeling after ionizing radiation steers thymocytes towards mitochondrial-driven pyroptotic cell death. We further identified that a key damage-associated molecular pattern (DAMP), ATP, stimulates the cell surface purinergic receptor P2Y2 on cortical thymic epithelial cells (cTECs) acutely after damage, enhancing expression of

Indexed as

ATPcell deathDAMPsmitochondriaP2Y2purinergic receptorspyroptosispyruvateThymus regeneration

Identifiers

PMID36711570
PMCPMC9882324
OpenAlexW4317653764

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.